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Abstract 
3-Arylsubstituted derivatives of 2H,3H,4H,7H- and 1H,2H,3H,4H-[1,2,4]triazolo[4,5-
a]pyrimidin-4-ones were synthesized from 2-arylidenehydrazino-6-methyl-4-pyrimidones by 
treatment with acetic anhydride. The structures of the starting compounds and of the isomeric di-
N-acetylated reaction products were established by NMR. 
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Guanylhydrazones (alkylenaminoguanidines, carboximideamidehydrazones, diaminomethylene 
hydrazones) are condensation products of oxo-compounds with aminoguanidines. This class of 
compounds has been known for a long time1 and is of considerable interest due to a wide variety 
of different pharmacological activities found with many representatives.2,3 Further, 
guanylhydrazones are valuable synthetic building blocks for ring closure reactions leading to 
several nitrogen-containing heterocycles.4,5 
In this context, we have published the transformation of (E)- aromatic aldehyde 
guanylhydrazones into 3-acylamino-5-aryl-1,2-diacetyl-4,5-dihydro-1,2,4-triazoles,6 the 
cyclization of N1-glycopyranosylamino)guanidines to 3-acetylamino-N1-glycopyranosyl-5-
methyl-1,2,4-triazoles,7 and the synthesis of N1-cycloalkenyl substituted 3-acylamino-5-methyl-
1,2,4-triazoles.8 All of these cyclisations are based on the reaction of guanylhydrazones with 
acetic anhydride in excess and proceed via an interesting type of ring closure mechanism through 
an acyliminium intermediate.5,6 
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However, some related educts with a guanylhydrazone structure (e.g. 2,6-
dichlorobenzaldehyde guanylhydrazone, various isatin guanylhydrazones or guanylhydrazones 
derived from (hetero)aryl methylketones) show different behavior and afford the corresponding 
N,N'-diacetyl derivatives upon treatment with acetic anhydride .6,9,10 It should be mentioned also 
that the attempted ring closure reaction of 2-amino-4-aryl-1-arylideneaminoimidazoles with 
several acid anhydrides led only to products acylated at various positions.11 Egyptian authors13 
investigated the reaction of 2-hydrazino-6-methyl-4-oxo-pyrimidine (1),12 a cyclic 
aminoguanidine derivative, with aldose monosaccharides that were supposed to react in their 
acyclic forms like simple aldehydes. The aldehydo-sugar(6-methyl-4-oxo-2-
pyrimidinyl)hydrazones obtained did not undergo cyclisation upon treatment with acetic 
anhydride.13 Others have studied cyclisation reactions of analogous N-heterocyclic hydrazones14-
16 and have established that the ring closure can follow two different pathways to result in the 
formation of polyaza-heterocycles with either linearly or angularly annellated rings14-16 (cf. 
Scheme 3 below). In view of the divergent results with regard to the structures of the products 
obtained from N-heterocyclic hydrazones under acylating conditions, we have investigated the 
reactions of 1 with simple aromatic aldehydes and subsequent transformations of the products 
upon treatment with acetic anhydride. 
 
 
Results and Discussion 
 
To study the ring closure, 2-arylidenehydrazino-6-methyl-4-oxo-pyrimidines (3) were prepared 
by the reaction of aromatic aldehydes 2 with 1. Compounds 3a-d were prepared in good yield 
with acetic acid catalysis in ethanol using a described procedure.17 Product 3a could be prepared 
also by the cyclisation of benzaldehyde-guanylhydrazone with ethyl acetoacetate catalyzed by 
acetic acid. The educts 3a-d were treated with acetic anhydride under reflux and two new 
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NMR studies 
Table 1. Relevant 13C NMR and 15N NMR chemical shifts (ppm) of hydrazones 3 in DMSO-d6 
  δC  δN 










































Table 2. Relevant 13C- and 15N chemical shifts (ppm) of the cyclisation products in DMSO-d6 a) 
or in CDCl3b) 
 C-3 C-4 C-5 C-6 C-7a N-1 N-2 N-4a N-7 
71.22 158.14 108.05 164.56 148.36 151.90 169.20 170.40 210.80 4a a) 





















4c b) 71.15 158.43 109.03 164.38 147.59 - 169.83 173.50 212.32 
4d a) 70.13 157.85 107.39 164.87 148.31 - - 164.90 208.10 
5d a) 71.37 157.96 95.89 153.10 146.35 206.83 169.58 147.53 108.36 
 
Arylidenehydrazones 
First, we set out to establish the structures of the condensation products of 1 with the aromatic 
aldehydes 2a-d. Knowledge of these structures is necessary to rationalize the subsequent 
reactions upon treatment with acetic anhydride. Elemental analyses and routine 1H- and 13C 
NMR spectra indicated formation of the expected hydrazone structures in the above reactions. 
Products 3a-d may, however, occur in three different tautomeric forms, I, II or III, each 
containing two sp2 and two sp3 nitrogens. Full characterization of these forms was achieved by 
































I. II. III.  
 
Scheme 2. Possible tautomers of arylidenehydrazones. 
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The NH-protons undergo fast exchange on the NMR time scale so they are not suitable for 
structural characterization. 15N-HMBC connectivities were, on the other hand, instrumental in 
determining the prevailing tautomeric form in each of the above cases. Inspection of formulas I-
III reveals that the 15N chemical shifts of N1 and N3 in the pyrimidine ring are of diagnostic 
value for this purpose. Assignments of these nitrogens are straightforward from the 15N-HMBC 
spectra; while H-5 can, in principle, be coupled to both N1 and N3, only N1 can give a cross 
peak to the CH3-6 protons. In fact, H-5 shows a HMBC correlation to a nitrogen with δN ∼145 
ppm in all hydrazones 3a-d, whereas the protons of CH3-6 are coupled to an aromatic N (δN 
∼186 ppm) in 3a, 3b and 3c and to an sp3-N (δN =119.2 ppm) in 3d. These chemical shifts 
clearly indicate the prevalence of tautomeric forms I for the former three derivatives and II for 
the fourth. Furthermore, occurrence of tautomer III can be safely excluded in all cases 
investigated. The 15N chemical shift values of the hydrazone nitrogens in Table 1 are in full 
agreement18 with these structures. In addition to tautomerism, the E/Z isomerism also is of 
interest in describing the structure of the hydrazones. The configuration about the CH=N – bond 
was found to be E in all four derivatives 3a-d from the fact that the 1JCH-values were less than 
∼170 Hz (Experimental); these values are expected to be significantly larger for the Z-
configuration.20 
 
Products obtained by acetylation 
13C-HMBC spectra of the acetylation products (4, 5) provide clear evidence of cyclisation 
reactions occurring during treatment of 3a-d with acetic anhydride. Specifically, the CH-proton 
at around 7 ppm in the 1H NMR spectra displays long-range couplings to C-2 and C-4 
pyrimidine carbons in each of the reaction products containing two acetyl groups. The 13C 
chemical shifts of these CHs, on the other hand, are much less (∼73 ppm) than that expected for a 
CH=N carbon (around 150 ppm) in each of the products. Therefore, the acylhydrazone structure 
(Scheme 3) can be safely discounted from further considerations. Furthermore, these 
observations eliminate structures originating from angular type ring closure (Scheme 3). 
The CH-proton of the triazole ring (H-3) displays long-range coupling to one of the acetyl 
carbonyl carbons in both products 4 and 5 (Scheme 4). H-3 is, in addition, weakly coupled (13C-
HMBC) to the other C=O carbon in 4a but not in 5a. This suggests structures for 4 and 5 as 
shown in Scheme 4. This hypothesis was then fully confirmed by determining the 15N chemical 
shifts through 15N-HMBC measurements. Specifically, N-7 is clearly an sp2, aromatic type N in 
4a-d whereas 15N chemical shifts indicate an sp3 amide type N-7 in 5a-d (Table 2). Key 1H/15N 
HMBC correlations allowing unequivocal 15N assignments are shown in Scheme 4. The above 
data therefore provide firm evidence for the structures of the ring closure products 4 and 5; their 
product distribution depending on the aryl substituent at C-3 (Experimental).  
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4 a-d 5 a-d  
Scheme 4. Relevant 13C- (thin lines) and 15N-HMBC (thick lines) correlations. 
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A possible mechanism for the ring closure reactions is set out in Scheme 3. Acyliminium ion 
A, depicted in two mesomeric forms A-1 and A-2, is supposed to form,5,6 as a first step, from 
tautomeric forms II of arylidenehydrazones 3a-d, via direct nucleophilic attack upon Ac2O. 
Form I may tautomerize into II under the reaction conditions. Ring closure can be effected by 
intramolecular nucleophilic attack either from ring N-3 or N-1 onto the formal carbocationic 
center in A-2, followed by deprotonation, leading to products B and C (route [1]) or D and E 
(route [2]). The single NH group in these intermediates is acetylated in situ in the presence of 
excess acetic anhydride. Since we could isolate N-acetylated derivatives (4 and 5) of 
[1,2,4]triazolo[4,5-a]pyrimidine tautomers (B and C) only and no products from the alternative 
structures D and E, route [1] appears to be favored over route [2] under the conditions employed. 
Inspection of Table 2 and 1H chemical shifts (see, Experimental) reveals that the chemical shifts 
of H-5, C-5 and C-6 are of diagnostic value in determining the positions of the N-acetyl groups 
and, therefore, discriminating between 4a-d vs. 5a-d. Namely, H-5, C-5 and C-6 are all shifted 
upfield significantly in the 5a-d isomers (typical values being ∼5, ~96 and ~152 ppm for H-5, C-
5 and C-6, respectively) with respect to those in their 4a-d counterparts (typical values at ~6, 
~108 and ~164 ppm, respectively, for H-5, C-5 and C-6). These chemical shift changes reflect 
the presence vs. absence of the acetyl group at N-7 through substituent effects on the respective 
carbons and the neighbour anisotropy of the acetyl carbonyl on the H-5 chemical shift, 
respectively. These characteristic differences have, on the other hand, a welcome practical 
consequence in that they make it easy to identify the isomeric structures by simply relying on 1D 
1H- and 13C-NMR spectra. 
In summary, we have determined the tautomeric forms and the configuration of the CH=N 
bond in pyrimidine hydrazones 3 by NMR. It has been established that cyclisation of hydrazones 
3 with acetic anhydride results in the exclusive formation of the linear type of heterobicycles 





General Procedures. Melting points were determined with a hot stage microscope F. Küstner & 
Nachf., Dresden. Column chromatography was performed on silica gel (Merck 40, 70-230 mesh) 
using ethyl acetate – ethanol = 70:1 as eluent. NMR spectra were recorded on a Bruker Avance 
DRX 500 (500.13 MHz for 1H, 125.77 MHz for 13C and 50.69 MHz for 15N) spectrometer. 
Chemical shifts (δ in ppm) are referenced to internal TMS for 1H NMR, 13CDCl3 (77.0) or 
DMSO-d6 (39.51) for 13C NMR and external nitromethane converted to external liquid ammonia 
scale (0.0) for 15N NMR. 
 
2-Arylidenehydrazino-6-methyl-4-pyrimidones (3a-d). The procedure of Doyle17 was 
modified as in reference 19: a mixture of aldehyde (10 mmol) and 2-hydrazino-6-methyl-4-
pyrimidone (1.40 g, 10 mmol) in ethanol (17 mL) was heated with 3 drops of acetic acid for the 
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given time. The product was filtered from the cooled reaction mixture and was dried under an 
infrared lamp. 
2-Benzylidenehydrazino-6-methyl-4-pyrimidone (3a). a., Using the general procedure, after 
40 min reaction time the yield was 2.05 g (89.8%), m.p.: 244-7°C (2-propanol). Anal. Calcd. for 
C12H12N4O (228.25): C, 63.14; H, 5.30; N, 24.54. Found: C, 62.89; H, 5.23; N, 24.42. 1H-NMR 
(DMSO-d6 , 500 MHz ): δ 10.35 (2H, NH); 8.05 (1H, CH=); 7.95-7.45 (3H, aromatic); 5.51 (1H, 
H-5); 2.09 (3H, CH3); 13C-NMR (DMSO-d6 , 125 MHz): δ 163.41 (C-6); 162.36 (C-4); 152.64 
(C-2); 144.63 (CH=, 1JCH =166Hz); 134.63 (C-1’); 129.67 (C-4’); 128.62 (C-2’); 127.62 (C-3’); 
101.64 (CH-5); 22.76 (CH3); 15N-NMR (DMSO-d6, 50.68 MHz): δ 320.60 (N-2B); 186.54 (N-1); 
166.87 (N-2A); 145.86 (N-3). 
b., Benzaldehyde guanylhydrazone (1.50 g, 10 mmol), ethyl acetoacetate (1.26 ml, 10 mmol) and 
1 drop of acetic acid in ethanol (6.5 ml) were refluxed for 6 h. The precipitate (0.9 g, 39 %) was 
recrystallized from 2-propanol, m.p.: 244-6°, Lit.17: 209°C. 
2-(1'-Naphthylidenehydrazino)-6-methyl-4-pyrimidone (3b). Using the general procedure, 
after 45 min reaction time the yield was 2.60 g (87.7 %), m.p.:202-203°C (ethanol). Anal. Calcd. 
for C16H14N4O·H2O (296.32): C, 64.85; H, 5.44; N, 18.91. Found: C, 64.69; H, 5,61; N, 18.97. 
1H-NMR (DMSO-d6 , 500 MHz ): δ 11.38 (2H, NH); 8.91 (1H, CH=); 8.55-7.54 (7H, aromatic); 
5.58 (1H, H-5); 2.08 (3H, 6-CH3); 13C-NMR (DMSO-d6 , 125 MHz): δ 163.30 (C-6); 162.44 (C-
4); 152.43 (C-2); 142.37 (CH=, 1JCH =161Hz); 133.35; 130.36; 129.46 (Cq-aromatic); 129.86; 
128.80; 126.94; 125.96; 125.75; 125.55; 122.59 (CH-aromatic); 101.65 (CH-5); 22.63 (CH3); 
15N-NMR (DMSO-d6, 50.68 MHz): δ 320.80 (N-2B); 187.50 (N-1); 168.81 (N-2A); 145.90 (N-
3). 
2-(3',4',5'-Trimethoxybenzylidenehydrazino)-6-methyl-4-pyrimidone (3c). Using the general 
procedure, after 2 hours reaction time the yield was 2.22 g (69 %), m.p.: 207-8°C (2-
propanol).Anal. Calcd. for C15H18N4O4 (318.32): C, 56.59; H, 5.70; N, 17.60. Found: C, 56.38; 
H, 5.61, N, 17.64. 1H-NMR (DMSO-d6 , 500 MHz ): δ 11.30 (2H, NH); 8.01 (1H, CH=); 7.20 
(2H, aromatic); 5.50 (1H, H-5); 3.82 (6H, 2x OCH3) ; 3.68 (3H, OCH3); 2.06 (3H, 6-CH3); 13C-
NMR (DMSO-d6 , 125 MHz): δ 163.45 (C-6); 162.68 (C-4); 153.25 (C-4’); 152.44 (C-2); 144.95 
(CH=); 139.11 (2x C-3’); 130.01 (C-1’); 105.04 (2x C-2’); 101.42 (CH-5); 60.19 (OCH3); 55.26 
(2x OCH3); 22.66 (6-CH3); 15N-NMR (DMSO-d6, 50.68 MHz): δ 317.90 (N-2B); 186.15 (N-1); 
167.20 (N-2A); 144.60 (N-3). 
2-(2',6'-Dichlorobenzylidenehydrazino)-6-methyl-4-pyrimidone (3d). Using the general 
procedure, after 10 min reaction time the yield was 2.72 g (91.5 %), m.p.: 230-31°C (ethyl 
acetate), lit.17 m.p.: 237-9oC. Anal. Calcd. for C12H10Cl2N4O (297.15): Cl, 23.86; N, 18.85. 
Found: Cl, 24.03; N, 18.82. 1H-NMR (DMSO-d6 , 500 MHz ): δ 11.10 (2H, NH); 8.31 (1H, CH=, 
1JCH =167Hz); 7.53-7.38 (3H, aromatic); 5.54 (1H, H-5); 2.10 (3H, 6-CH3); 13C-NMR (DMSO-
d6 , 125 MHz): δ 161.97 (C-6); 161.26 (C-4); 152.38 (C-2); 140.23 (CH=, 1JCH =163Hz); 133.83 
(2x C-2’); 130.57 (C-4’); 129.91 (C-1’); 128.78 (2x C-3’); 101.18 (CH-5); 21.05 (6-CH3); 15N-
NMR (DMSO-d6, 50.68 MHz): δ 340.10 (N-2B); 144.39 (N-3); not observed (N-2A); 119.20 (N-
1). 
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General procedure for cyclization of 3a-d.  
Compound 3 (2 mmol) was refluxed in acetic anhydride (1.6 mL) for 10-25 min. The volatiles 
were evaporated in vacuo. Codistillation with toluene (3 x 12 ml) gave rise to the crude products. 
Pure 4 and 5 were obtained by crystallization or column chromatographic separation (ethyl 
acetate : ethanol = 80:1).  
 
(3R,S)-1H,2H,3H,4H-Tetrahydro-1,2-diacetyl-3-phenyl-6-methyl-[1,2,4]triazolo[4,5-
a]pyrimidin-4-one (4a). Using the general procedure with 3a, the crude product was separated 
by column chromatography. The first fraction contained 4a, yield: 0.394 g (63 %), mp.: 150-
52°C. Anal. Calcd. for C16H16N4O3 (312.32): C, 61.53; H, 5.16; N, 17.94. Found: C, 61.65; H, 
5.07; N, 17.88. 1H-NMR (DMSO-d6, 500 MHz ): δ 7.45-7.30 (3H, aromatic); 7.05 (1H, H-3); 
5.05 (1H, H-5); 2.64 (3H, 2-CH3); 2.28 (3H, 6-CH3); 2.07 (3H, 1-CH3); 13C-NMR (DMSO-d6, 
125 MHz): δ 174.05 (CO-Ac-1); 167.90 (CO-Ac-2); 164.56 (C-6); 158.14 (C-4); 148.36 (C-7a); 
137.41 (C-1’); 129.50 (C-4’); 128.72 (C-2’); 128.28 (C-3’); 108.05 (CH-5); 71.22 (CH-3); 23.47 
(CH3-Ac-2); 22.46 (CH3-Ac-1); 20.65 (6-CH3); 15N-NMR (DMSO-d6, 50.68 MHz): δ 210.80 (N-
7); 170.40 (N-4a); 169.20 (N-2); 151.90 (N-1). 
(3R,S)-2H,3H,4H,7H-Tetrahydro-2,7-diacetyl-3-phenyl-6-methyl-[1,2,4]triazolo[4,5-
a]pyrimidin-4-one (5a). The second fraction in the foregoing reaction contained amorphous 
product 5a, yield 0.013 g (2.0 %), mp.: 217-24 °C. Anal. Calcd. for C16H16N4O3 (312.32): C, 
61.53; H, 5.16; N, 17.94. Found: C, 61.65; H, 5.08, N, 17.76. 1H-NMR (DMSO-d6, 500 MHz ): δ 
6.87 (1H, H-3); 7.45-7.30 (3H, aromatic); 5.10 (1H, H-5); 2.05 (3H, 6-CH3); 2.02 (3H, CH3-Ac-
2); 1.92 (3H, CH3-Ac-7); 13C-NMR (DMSO-d6, 125 MHz): δ 171.97 (CO-Ac-7); 165.16 (CO-
Ac-2); 167.69 (C-4); 152.76 (C-6); 146.47 (C-7a); 137.59 (C-1’); 128.61 (C-4’); 128.47 (C-2’); 
126.92 (C-3’); 96.40 (CH-5); 73.62 (CH-3); 20.95 (6-CH3 and CH3-Ac-7); 18.40 (CH3-Ac-
2);15N-NMR (DMSO-d6, 50.68 MHz): δ 202.60 (N-1); 176.40 (N-2); 131.30 (N-4a); 109.82 (N-
7). 
(3R,S)-1H,2H,3H,4H-Tetrahydro-1,2-diacetyl-3-(1'-naphthyl)-6-methyl-[1,2,4]triazolo[4,5-
a]pyrimidin-4-one (4b). Using the general procedure with 3b, the crude product was 
crystallized from ethanol, to give pure 4b, yield 0.50 g (69 %), mp.: 202-204°C. Anal. Calcd. for 
C20H18N4O3 (362.25): C, 66.31; H, 4.97, N, 15.47. Found: C, 66.17; H, 4.99; N, 15.53. 1H-NMR 
(CDCl3, 500 MHz ): δ 8.65-6.66 (7H, aromatic); 8.21 (1H, H-3); 6.12 (1H, H-5); 2.30 (3H, 6-
CH3); 2.10 (6H, CH3-Ac-1 and -2); 13C-NMR (CDCl3, 125 MHz): δ 175.75 (7-CO); 164.99 (C-
6); 158.00 (C-4); 148.90 (C-7a); 133.66; 129.98; 127.75 (Cq-aromatic); 130.58; 128.28; 126.97; 
126.20; 124.20; 122.94; 121.28 (CH-aromatic); 108.85 (CH-5); 68.55 (CH-3); 23.57 (6-CH3); 
20.56 (CH3-Ac-1 and-2); 15N-NMR (CDCl3, 50.68 MHz): δ 214.05.10 (N-7); 168.05 (N-4a); 
166.10 (N-2); 151.50 (N-1). 
 (3R,S)-2H,3H,4H,7H-Tetrahydro-2,7-diacetyl-3-(1'-naphthyl)-6-methyl-[1,2,4]triazolo[4,5-
a]pyrimidin-4-one (5b). The mother liquor from 4b was evaporated to dryness and the residue 
purified by column chromatography to produce 0.07 g (1 %) of 5b as an amorphous product. 
Anal. Calcd. for C20H18N4O3 (362.25). C, 66.31; H, 4.97; N, 15.47. Found: C, 66.24; H, 4.82; N, 
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15.34. 1H-NMR (DMSO-d6, 500 MHz ): δ 8.41-7.35 (7H, aromatic); 7.58 (1H, H-3); 5.02 (1H, 
H-5); 2.01 (6H, 6-CH3 and CH3-Ac-7); 1.92 (3H, CH3-Ac-2); 13C-NMR (DMSO-d6, 125 MHz): 
δ 172.17 (7-CO); 165.49 (2-CO); 157.98 (C-4); 152.94 (C-6); 146.81 (C-7a); 134.40; 133.29; 
129.57 (Cq-aromatic); 128.72; 126.47; 125.83; 125.53; 123.41 (CH-aromatic); 96.40 (CH-5); 
72.10 (CH-3); 21.20 (CH3-Ac-2); 20.99 (CH3-Ac-7); 18.50 (6-CH3); 15N-NMR (DMSO-d6, 50.68 
MHz): δ 156.10 (N-4a); 110.30 (N-7); not observed (N-1), (N-2). 
(3R,S)-1H,2H,3H,4H-Tetrahydro-1,2-diacetyl-3-(3',4',5'-trimethoxyphenyl)-6-methyl-[1,2,4] 
triazolo -[4,5-a]pyrimidin-4-one (4c). Using the general procedure with 3c, the reaction mixture 
contained only 4c, yield 0.70 g (91 %), mp.: 173-176°C (Ethyl acetate - hexane). Anal. Calcd. 
for C18H22N4O6 (384.39): C, 61.00; H, 5.76; N, 14.57. Found: C, 60.93; H, 5.67; N, 14.50. 1H-
NMR (CDCl3 , 500 MHz ): δ 7.40 (1H, H-3); 6.90 (2H, aromatic); 6.05 (1H, H-5); 3.78 (6H, 
OCH3); 3.74 (3H, OCH3); 2.67 (3H, CH3-Ac-2); 2.21 (3H, 6-CH3); 2.19 (3H, CH3-Ac-1); 13C-
NMR (CDCl3, 125 MHz): δ 173.46 (2-CO); 167.58 (1-CO); 164.38 (C-6); 158.43 (C-4); 153.31 
(C-3’); 147.59 (C-7a); 138.52 (C-4’); 128.92 (C-1’); 109.03 (CH-5); 103.09 (C-2’); 71.15 (CH-
3); 60.37 (OCH3); 55.83 (2x OCH3); 23.53 (6-CH3); 22.44 (CH3-Ac-1); 20.29 (CH3-Ac-2); 15N-
NMR (CDCl3, 50.68 MHz): δ not observed (N-1); 212.32 (N-7); 173.50 (N-4a); 169.83 (N-2). 
(3R,S)-2H,3H,4H,7H-Tetrahydro-2,7-diacetyl-3-(2',6'-dichlorophenyl)-6-methyl-[1,2,4]triazolo 
[4,5-a]pyrimidin-4-one (5d). The crude product obtained from 3d, using the general procedure, 
was crystallized from ethanol to yield 5d, 0.46 g (60.4 %). Mp.: 286-291°C. Anal. Calcd. for 
C16H14Cl2N4O3 (381.22): C, 50.40; H, 3.70; N, 14.70. Found: C, 50.29; H, 3.65; N, 14.62. 1H-
NMR (DMSO-d6, 500 MHz ): δ 7.49 (1H, H-3); 7.45-7.34 (3H, aromatic); 5.03 (1H, H-5); 2.01 
(6-CH3); 1.99 (CH3-Ac-2 and-7); 13C-NMR (DMSO-d6, 125 MHz): δ 171.84 (7-CO); 162.51 (2-
CO); 157.96 (C-4); 153.10 (C-6); 146.35 (C-7a); 137.07 (C-1’); 132.95 (C-2’); 130.25 (C-6’); 
130.85; 129.98; 128.82 (CH-aromatic); 95.89 (CH-5); 71.37 (CH-3); 20.74 (6-CH3); 18.55 (CH3-
Ac-2 and-7); 15N-NMR (DMSO-d6, 50.68 MHz): δ 206.83 (N-1); 169.58 (N-2); 147.53 (N-4a); 
108.36 (N-1).  
(3R,S)-1H,2H,3H,4H-Tetrahydro-1,2-diacetyl-3-(2',6'-dichlorophenyl)-6-methyl-[1,2,4]triazolo 
-[4,5-a]pyrimidin-4-one (4d). The mother liquor from 5d was evaporated to dryness and the 
residue purified by column chromatography to produce 4d as an amorphous product, yield 0.10 g 
(13 %). 1H-NMR (DMSO-d6, 500 MHz ): δ 7.45 (1H, H-3); 7.35-7.40 (3H, aromatic); 6.10 (1H, 
H-5); 2.27 (3H, 6-CH3); 2.19 (3H, CH3-Ac-1); 2.01 (3H, CH3-Ac-2); 13C-NMR (CDCl3, 125 
MHz): δ 171.52 (2-CO); 164.87 (1-CO); 157.85 (C-6); 152.82 (C-4); 148.31 (C-7a); 136.76 (C-
1’); 133.93 (C-2’); 133.10 (C-6’); 130.30; 129.65; 129.34 (CH-aromatic); 107.39 (CH-5); 70.13 
(CH-3); 23.54 (6-CH3); 22.99 and 20.29 (CH3-Ac-1,-2); 15N-NMR (CDCl3, 50.68 MHz): δ not 
observed (N-1); (N-2); 208.10 (N-7); 164.90 (N-4a);  
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